Kesios Therapeutics
develops novel therapeutics for the treatment of multiple myeloma and other cancers... Read moreKesios Therapeutics
develops novel therapeutics for the treatment of multiple myeloma and other cancers... Read more
CEO
Paolo Paoletti
News
Dec 02, 2015
BioSpace
Kesios Therapeutics: Imperial Innovations Release: Innovations Portfolio Company Raises ??19 Million In Series A Funding Round
Dec 02, 2015
BioSpace
Kesios Therapeutics: With Former GlaxoSmithKline Cancer Chief at Its Helm, Locks In $28.5 Million
Dec 02, 2015
BioPortfolio
Kesios Therapeutics: Kesios Gets Funding To Explore Novel Multiple Myeloma Pathway
Dec 02, 2015
The Pharma Letter
Kesios Therapeutics: Kesios Therapeutics raises £19 million; names executives
Dec 02, 2015
FinSMEs
Kesios Therapeutics: Kesios Therapeutics Closes £19M Series A Financing
Dec 02, 2015
4-traders
Kesios Therapeutics: Imperial Innovations : Invests In Series A Funding Round For Kesios
Dec 02, 2015
Business Wire
Press Release: Kesios : Kesios Therapeutics Raises £19 Million in Series A Financing
Jun 01, 2015
BIOPORTFOLIO
Kesios: Paolo Paoletti named as executive chairman of Kesios Therapeutics
May 29, 2015
THE PHARMA LETTER
Kesios: Paolo Paoletti appointed executive chairman of Kesios
May 29, 2015
BUSINESS WIRE
Press Release: Kesios : Imperial Innovations Group plc: Appointment of Paolo Paoletti as Executive Chairman of Kesios Therapeutics
Kesios Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10